NO20000293L - Preparater, kits og fremgangsmõter for inhibering av cerebrale neurovaskulære forstyrrelser og muskulære hodepiner - Google Patents
Preparater, kits og fremgangsmõter for inhibering av cerebrale neurovaskulære forstyrrelser og muskulære hodepinerInfo
- Publication number
- NO20000293L NO20000293L NO20000293A NO20000293A NO20000293L NO 20000293 L NO20000293 L NO 20000293L NO 20000293 A NO20000293 A NO 20000293A NO 20000293 A NO20000293 A NO 20000293A NO 20000293 L NO20000293 L NO 20000293L
- Authority
- NO
- Norway
- Prior art keywords
- local anesthetic
- methods
- headaches
- muscular
- patient
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 206010019233 Headaches Diseases 0.000 title abstract 4
- 230000002490 cerebral effect Effects 0.000 title abstract 4
- 231100000869 headache Toxicity 0.000 title abstract 4
- 208000017376 neurovascular disease Diseases 0.000 title abstract 4
- 230000003387 muscular Effects 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 2
- 230000002401 inhibitory effect Effects 0.000 title 1
- 239000003589 local anesthetic agent Substances 0.000 abstract 5
- 239000000203 mixture Substances 0.000 abstract 3
- 208000006561 Cluster Headache Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 206010027603 Migraine headaches Diseases 0.000 abstract 1
- 206010043269 Tension headache Diseases 0.000 abstract 1
- 208000008548 Tension-Type Headache Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000004118 muscle contraction Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000007910 systemic administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Otolaryngology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89719297A | 1997-07-21 | 1997-07-21 | |
| US7284598P | 1998-01-28 | 1998-01-28 | |
| US8455998P | 1998-05-06 | 1998-05-06 | |
| PCT/US1998/014870 WO1999003473A1 (en) | 1997-07-21 | 1998-07-17 | Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20000293D0 NO20000293D0 (no) | 2000-01-20 |
| NO20000293L true NO20000293L (no) | 2000-03-20 |
Family
ID=27372174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000293A NO20000293L (no) | 1997-07-21 | 2000-01-20 | Preparater, kits og fremgangsmõter for inhibering av cerebrale neurovaskulære forstyrrelser og muskulære hodepiner |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0999839B1 (https=) |
| JP (1) | JP4521117B2 (https=) |
| KR (1) | KR20010022041A (https=) |
| CN (1) | CN1267219A (https=) |
| AR (1) | AR013240A1 (https=) |
| AT (1) | ATE269702T1 (https=) |
| AU (1) | AU8574398A (https=) |
| BR (1) | BR9810773A (https=) |
| CA (1) | CA2297097C (https=) |
| DE (1) | DE69824730T2 (https=) |
| EE (1) | EE200000050A (https=) |
| HU (1) | HUP0003953A3 (https=) |
| ID (1) | ID24903A (https=) |
| IL (2) | IL134087A0 (https=) |
| IS (1) | IS5349A (https=) |
| NO (1) | NO20000293L (https=) |
| PL (1) | PL338176A1 (https=) |
| SK (1) | SK187899A3 (https=) |
| TR (1) | TR200000149T2 (https=) |
| WO (1) | WO1999003473A1 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9704349D0 (en) * | 1997-03-03 | 1997-04-23 | Chiroscience Ltd | Levobupivacaine and its use |
| JP4632499B2 (ja) * | 1999-08-26 | 2011-02-16 | 武田薬品工業株式会社 | 鼻粘膜付着マトリックス |
| AU2100901A (en) * | 1999-12-15 | 2001-06-25 | Bruce H. Levin | Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation |
| GB9930083D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Medicaments |
| US7640062B2 (en) | 2000-05-08 | 2009-12-29 | Brainsgate Ltd. | Methods and systems for management of alzheimer's disease |
| US6853858B2 (en) | 2000-05-08 | 2005-02-08 | Brainsgate, Ltd. | Administration of anti-inflammatory drugs into the central nervous system |
| US7117033B2 (en) | 2000-05-08 | 2006-10-03 | Brainsgate, Ltd. | Stimulation for acute conditions |
| US7146209B2 (en) | 2000-05-08 | 2006-12-05 | Brainsgate, Ltd. | Stimulation for treating eye pathologies |
| JP4311904B2 (ja) | 2000-05-08 | 2009-08-12 | ブレインスゲート リミテッド | 血液脳関門及び脳血流の性質を改善するための翼口蓋神経節の刺激方法及び装置 |
| WO2004043218A2 (en) | 2002-11-14 | 2004-05-27 | Brainsgate Ltd. | Surgical tools and techniques for stimulation |
| US7561919B2 (en) | 2002-11-14 | 2009-07-14 | Brainsgate Ltd. | SPG stimulation via the greater palatine canal |
| WO2005062829A2 (en) | 2003-12-19 | 2005-07-14 | Advanced Bionics Corporation | Skull-mounted electrical stimulation system and method for treating patients |
| US8055347B2 (en) | 2005-08-19 | 2011-11-08 | Brainsgate Ltd. | Stimulation for treating brain events and other conditions |
| US9233245B2 (en) | 2004-02-20 | 2016-01-12 | Brainsgate Ltd. | SPG stimulation |
| US8010189B2 (en) | 2004-02-20 | 2011-08-30 | Brainsgate Ltd. | SPG stimulation for treating complications of subarachnoid hemorrhage |
| JP4843824B2 (ja) | 2004-08-18 | 2011-12-21 | 株式会社 メドレックス | 外用剤 |
| CN102112112A (zh) * | 2008-07-21 | 2011-06-29 | 奥德纳米有限公司 | 用于治疗耳部病症的受控释放抗微生物组合物和方法 |
| DE102008037682A1 (de) | 2008-08-14 | 2010-04-08 | Strackharn, Klaus, Dr.med. | Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen |
| EP2903604A1 (en) | 2012-09-28 | 2015-08-12 | St. Renatus, LLC | Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines |
| CN103432378A (zh) * | 2013-08-15 | 2013-12-11 | 吕清华 | 一种治疗神经血管性头痛的中药 |
| EP2878335B1 (en) | 2013-11-10 | 2018-01-03 | Brainsgate Ltd. | Implant and delivery system for neural stimulator |
| US10271907B2 (en) | 2015-05-13 | 2019-04-30 | Brainsgate Ltd. | Implant and delivery system for neural stimulator |
| EP3897603A4 (en) * | 2018-12-19 | 2022-09-14 | Grace Therapeutics Inc. | THERAPEUTIC COMPOSITION OF INTRANASAL LIDOCAINE |
| EP3914246A1 (en) * | 2019-01-22 | 2021-12-01 | ICM (Institut du Cerveau et de la Moelle Épinière) | Local anesthetic for the treatment of neurological symptoms resulting from brain dysfunctions |
| GB2628149A (en) * | 2023-03-16 | 2024-09-18 | Lee Nathaniel Wurie | Nasal spray for performing sphenopalatine ganglion block |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321061D0 (en) * | 1993-10-13 | 1993-12-01 | Chiroscience Ltd | Analgestic agent and its use |
| DE19524691A1 (de) * | 1995-07-06 | 1997-01-09 | Liedtke Pharmed Gmbh | Methode und Zusammensetzung einer topischen Therapie von Innenohr und Labyrinth-Symptomen |
| DE19526019A1 (de) * | 1995-07-17 | 1997-01-23 | Liedtke Pharmed Gmbh | Methode und Zusammensetzung einer topischen Therapie von Kopfschmerzen |
| BE1009851A3 (fr) * | 1996-01-11 | 1997-10-07 | Thiebauld Charles Marie | Composition pharmaceutique pour le traitement des cephalees et son utilisation. |
| GB2315673A (en) * | 1996-08-01 | 1998-02-11 | Merck & Co Inc | Treatment of migraine |
| US5891885A (en) * | 1996-10-09 | 1999-04-06 | Algos Pharmaceutical Corporation | Method for treating migraine |
| GB9704349D0 (en) * | 1997-03-03 | 1997-04-23 | Chiroscience Ltd | Levobupivacaine and its use |
-
1998
- 1998-07-17 AU AU85743/98A patent/AU8574398A/en not_active Abandoned
- 1998-07-17 CN CN98808214A patent/CN1267219A/zh active Pending
- 1998-07-17 AT AT98936893T patent/ATE269702T1/de not_active IP Right Cessation
- 1998-07-17 KR KR1020007000610A patent/KR20010022041A/ko not_active Withdrawn
- 1998-07-17 HU HU0003953A patent/HUP0003953A3/hu unknown
- 1998-07-17 IL IL13408798A patent/IL134087A0/xx active IP Right Grant
- 1998-07-17 WO PCT/US1998/014870 patent/WO1999003473A1/en not_active Ceased
- 1998-07-17 SK SK1878-99A patent/SK187899A3/sk unknown
- 1998-07-17 PL PL98338176A patent/PL338176A1/xx unknown
- 1998-07-17 ID IDW20000123D patent/ID24903A/id unknown
- 1998-07-17 TR TR2000/00149T patent/TR200000149T2/xx unknown
- 1998-07-17 JP JP2000502772A patent/JP4521117B2/ja not_active Expired - Fee Related
- 1998-07-17 EP EP98936893A patent/EP0999839B1/en not_active Expired - Lifetime
- 1998-07-17 EE EEP200000050A patent/EE200000050A/xx unknown
- 1998-07-17 BR BR9810773-9A patent/BR9810773A/pt not_active IP Right Cessation
- 1998-07-17 CA CA002297097A patent/CA2297097C/en not_active Expired - Lifetime
- 1998-07-17 DE DE69824730T patent/DE69824730T2/de not_active Expired - Lifetime
- 1998-07-21 AR ARP980103565A patent/AR013240A1/es unknown
-
2000
- 2000-01-17 IL IL134087A patent/IL134087A/en not_active IP Right Cessation
- 2000-01-18 IS IS5349A patent/IS5349A/is unknown
- 2000-01-20 NO NO20000293A patent/NO20000293L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0999839A1 (en) | 2000-05-17 |
| AU8574398A (en) | 1999-02-10 |
| KR20010022041A (ko) | 2001-03-15 |
| HUP0003953A1 (hu) | 2002-01-28 |
| DE69824730D1 (de) | 2004-07-29 |
| WO1999003473A1 (en) | 1999-01-28 |
| DE69824730T2 (de) | 2005-07-14 |
| CN1267219A (zh) | 2000-09-20 |
| PL338176A1 (en) | 2000-10-09 |
| JP4521117B2 (ja) | 2010-08-11 |
| ID24903A (id) | 2000-08-31 |
| ATE269702T1 (de) | 2004-07-15 |
| IL134087A0 (en) | 2001-04-30 |
| EP0999839B1 (en) | 2004-06-23 |
| BR9810773A (pt) | 2000-09-19 |
| CA2297097C (en) | 2009-04-07 |
| HUP0003953A3 (en) | 2002-02-28 |
| IS5349A (is) | 2000-01-18 |
| NO20000293D0 (no) | 2000-01-20 |
| TR200000149T2 (tr) | 2000-05-22 |
| AR013240A1 (es) | 2000-12-13 |
| IL134087A (en) | 2006-10-31 |
| JP2001513483A (ja) | 2001-09-04 |
| EE200000050A (et) | 2000-10-16 |
| CA2297097A1 (en) | 1999-01-28 |
| SK187899A3 (en) | 2000-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20000293L (no) | Preparater, kits og fremgangsmõter for inhibering av cerebrale neurovaskulære forstyrrelser og muskulære hodepiner | |
| WO2001062236A3 (en) | New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent | |
| NO980592L (no) | Nye opioidpeptider | |
| NO20015931L (no) | Farmasöytiske formuleringer og fremgangsmåter som omfatter intranasal morfin | |
| NO20043531L (no) | Indazolforbindelser som er nyttige som proteinkinaseinhibitorer | |
| DK1076657T3 (da) | Hidtil ukendte hydroxyindoler, deres anvendelse som inhibitorer for phosphodiesterase 4 og fremgangsmåde til deres fremstilling | |
| BR9917038A (pt) | Composto, composição farmacêutica, método de modulação da atividade receptora de quimocinas, método de tratamento ou prevenção de doenças inflamatórias, método de tratamento ou prevenção de asma e método de tratamento ou prevenção de disfunções inflamatórias | |
| CA2375908A1 (en) | Highly selective norepinephrine reuptake inhibitors and methods of using the same | |
| EP0919234A3 (en) | Potentiation of pharmaceuticals by moxonidine | |
| DK0668863T3 (da) | Quinuclidinderivat som substans P-antagonist | |
| AU2002225772A1 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
| EA200901492A1 (ru) | Лечение доброкачественной гиперплазии простаты селективным модулятором рецептора андрогенов (sarm) | |
| TR200001279T2 (tr) | Poli (ADP-riboz) polimeraz ("PARP") inhibitörleri, nevral ve kardiyovasküler doku hasarının tedavisi için yöntemler ve farmasötik bileşimler. | |
| NO20056252L (no) | Terapeutiske og profylaktiske metoder for neuromuskulaere lidelser | |
| BR0213040A (pt) | Composto, processo para preparar um composto, e, método de tratar doenças | |
| BR9806157A (pt) | Composições farmacêuticas de descarboetoxiloratadina anidras, não higroscópicas e sem lactose | |
| NO954878L (no) | Pyrrolderivater | |
| WO2001043733A3 (en) | Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation | |
| ES2136252T3 (es) | Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa. | |
| EE04491B1 (et) | (+)-nortsisapriidi kasutamine | |
| NO992062L (no) | Preparat for behandling av astma, inneholdende loratadin og et dekongestionsmiddel | |
| SE9603725D0 (sv) | New teatment | |
| MX9701820A (es) | Compuestos de pirazolo [3,4-g] quinoxalina que inhiben proteina tirosina quinasa receptora de pdgf. | |
| EP1064966A3 (en) | Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine | |
| HK1051485A1 (zh) | 增生性疾病的治療 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |